[Federal Register Volume 84, Number 226 (Friday, November 22, 2019)]
[Notices]
[Page 64562]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25407]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-550]


Importer of Controlled Substances Application: Janssen 
Pharmaceuticals, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before December 23, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before December 23, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:  In accordance with 21 CFR 1301.34(a), this 
is notice that on October 9, 2019, Janssen Pharmaceuticals, Inc., 1440 
Olympic Drive, Athens, Georgia 30601-1645 applied to be registered as 
an importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
          Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Thebaine................................            9333              II
Concentrate of Poppy Straw..............            9670              II
Tapentadol..............................            9780              II
------------------------------------------------------------------------

    The company plans to import intermediate forms of tapentadol (9780) 
and thebaine (9333) for further manufacturing prior to distribution to 
its customers. The company plans to import concentrate of poppy straw 
(9670) to bulk manufacture other controlled substances. No other 
activity for these drug codes is authorized for this registration.

    Dated: November 8, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-25407 Filed 11-21-19; 8:45 am]
 BILLING CODE 4410-09-P